Contact us for free information or to start a free case review.
Zyprexa maker Eli Lilly maintains there is no conclusive information on Zyprexa showing the antipsychotic drug has a risk of deadly and serious side effects. For the 288 reported diabetes cases in Zyprexa patients, with 23 of them resulting in death, that information on Zyprexa is conclusive enough. The available information on Zyprexa was enough to lead Japan and the European Union to require that the company include a clear diabetes risk warning on Zyprexa product information sheets.
The FDA has been criticized for failing to provide adequate information on Zyprexa to U.S. doctors and patients. Unlike other countries, the FDA has not required that Zyprexa labeling or informational packets provide more information on Zyprexa to make it clearer of possible risks of the drug. Though risks of the drug might be considered to outweigh its risks in severe cases, Zyprexa is being indicated more and more for minor conditions that could be treated with a less risky drug if patients were given the information on Zyprexa available. Consumer advocacy group Public Citizen has openly criticized the FDA’s failure to provide more information on Zyprexa to patients and people considering Zyprexa treatment.
On March 6, 2008, the State of Alaska provided its opening arguments in a lawsuit against the maker of the schizophrenia drug Zyprexa.
The lawsuit contends that the pharmaceutical giant Eli Lilly played down the diabetes and weight gain The maker of the popular antipsychotic drug Zyprexa is in talks to settle state and federal claims over the company’s marketing practices for more than $1 billion, potentially the... Strong new warnings were added to the label of the top-selling antipsychotic Zyprexa last week, alerting patients and physicians to the increased risk of high blood sugar and » Read More "Makers of Zyprexa may Settle Suit"
"High Blood Sugar and Weight Gain Risks"
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.